Audits & Inspection Readiness
Ensuring Global Compliance & Operational Excellence
Stay ahead of regulatory risk with comprehensive GxP audits and inspection readiness services designed for pharmaceutical, biotechnology, and cell and gene therapy organizations.
In today’s highly regulated life sciences environment, compliance with FDA and global regulatory expectations requires precision, consistency, and operational transparency.
Our team of former FDA investigators and senior pharmaceutical and biotechnology quality experts conduct deep-dive audits and realistic mock inspections across all GxP areas, including GMP, GLP, and GCP.
We evaluate:
-
System vulnerabilities
-
Data integrity controls
-
Quality systems and documentation
-
End-to-end operational readiness
across the entire product lifecycle, from early development through commercial manufacturing.
The result is a strengthened quality and compliance framework that supports:
-
Regulatory inspection readiness
-
Robust documentation practices
-
Sustainable GMP, GLP, and GCP compliance
Whether advancing a novel biologic, scaling a cell or gene therapy platform, or managing global pharmaceutical supply chains, we ensure your organization is prepared for FDA inspections and international regulatory audits—every time.
Data Integrity Audits
GxP Compliance Audits
Comprehensive audit services covering Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), and Good Clinical Practice (GCP) to ensure full regulatory compliance across all operational areas.
GMP Audits
Good Manufacturing Practices (GMP) are essential for ensuring that medical products are consistently produced and controlled according to rigorous quality standards and regulatory expectations. Maintaining compliance requires deep expertise in designing, implementing, and continuously improving GMP quality systems.
​
Our GMP audit services:
-
Evaluate manufacturing systems and processes
-
Identify compliance risks and quality gaps
-
Strengthen quality management systems (QMS)
-
Support continuous improvement and inspection readiness
Led by former FDA investigators and industry experts, we help organizations build scalable, compliant manufacturing operations that meet and exceed global regulatory expectations.
GLP Audits
GLP Audits (Good Laboratory Practice)
Good Laboratory Practice (GLP) audits ensure the integrity, reliability, and traceability of laboratory data used in regulatory submissions.
​
Our GLP audit services:
-
Assess laboratory systems, workflows, and documentation
-
Identify data integrity risks and compliance gaps
-
Strengthen controls for regulatory readiness
-
Support long-term laboratory compliance and operational excellence
We help laboratories achieve the highest standards of scientific rigor and regulatory compliance required by global health authorities.
GCP Audits
Our Good Clinical Practice (GCP) audit services are designed to help you navigate complex clinical and regulatory requirements while strengthening research quality across the entire clinical trial lifecycle.
We deliver objective, risk-based assessments that support compliance, enhance data integrity, and prepare your organization for FDA and global regulatory inspections.
GCP Audits
Our GCP audit expertise includes:
-
Investigator Site Audits
Evaluation of site conduct, documentation, subject safety, and protocol adherence -
Sponsor and Vendor Audits
Assessments of sponsors, CROs, and clinical research partners to ensure proper oversight and compliance -
System and Process Audits
Review of quality systems, SOPs, and operational workflows to identify gaps and drive improvement -
For-Cause Audits
Targeted investigations addressing specific risks or compliance concerns -
Phase I Audits
Specialized audits for early-phase clinical research units and studies -
Regulatory Inspection Readiness Audits
Preparation for FDA, EMA, and other global regulatory authority inspections -
Mock Inspections
Realistic simulations to evaluate preparedness and strengthen team response -
Document Audits
In-depth review of CSRs, ICFs, protocols, and essential study documentation -
eTMF Audits
Evaluation of Trial Master Files for completeness, accuracy, and compliance -
Pharmacovigilance Audits
Assessment of safety systems and global reporting requirements -
Data Management Audits
Review of data handling, validation processes, and data integrity controls -
BA/BE Audits
Audits focused on bioavailability and bioequivalence study compliance
Ensure every sample, method, instrument, record, and data transfer supporting your clinical trials meets Good Clinical Laboratory Practice (GCLP) expectations and withstands regulatory scrutiny, including rigorous controls for patient sample testing
Quality System Audits
Expose compliance gaps before the FDA does—with comprehensive quality system audits that evaluate every component of your operations against current regulations and industry best practices. Our assessments strengthen oversight, reinforce quality controls, and help ensure your organization is fully prepared for regulatory scrutiny.
Vendor and Supplier Audits
✓
Risk-Based Selection: We implement specialized audit methodologies for high-risk critical suppliers, ensuring quality standards are maintained across the global supply chain.
✓
Mitigating Quality Risks: Our comprehensive inspections identify potential weak points in raw material sourcing and technical partnerships before they impact manufacturing.
✓
Regulatory Resilience: We ensure all third-party vendors meet international GxP standards, providing you with audit-ready documentation and supplier oversight strategies.
Gap Assessments
Our gap assessments give you a clear, honest view of how your current operations align with evolving FDA and global regulatory expectations.
We evaluate key areas including quality management systems (QMS), CMC documentation, laboratory practices, and broader operational processes to identify deficiencies and quantify risk. More importantly, we translate those findings into clear, actionable steps—so your team knows exactly what to fix, why it matters, and how to move forward.
The result is a focused, practical roadmap that not only closes compliance gaps, but strengthens your organization for long-term success and inspection readiness